First Time Loading...
S

Shandong Pharmaceutical Glass Co Ltd
SSE:600529

Watchlist Manager
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Watchlist
Price: 28.63 CNY -0.66%
Updated: Mar 29, 2024

Intrinsic Value

Shandong Pharmaceutical Glass Co., Ltd. engages in the research and development, production, and sale of medical glass packaging materials. [ Read More ]

The intrinsic value of one Shandong Pharmaceutical Glass Co Ltd stock under the Base Case scenario is 37.21 CNY. Compared to the current market price of 28.63 CNY, Shandong Pharmaceutical Glass Co Ltd is Undervalued by 23%.

Key Points:
Intrinsic Value
Base Case
37.21 CNY
Undervaluation 23%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation Backtest
Shandong Pharmaceutical Glass Co Ltd

Backtest Shandong Pharmaceutical Glass Co Ltd Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling Shandong Pharmaceutical Glass Co Ltd stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

How can I assist you today?

Provide an overview
of Shandong Pharmaceutical Glass Co Ltd's business.

What risks and challenges
does Shandong Pharmaceutical Glass Co Ltd face in the near future?

Summarize the latest earnings report
of Shandong Pharmaceutical Glass Co Ltd.

Provide P/E
for Shandong Pharmaceutical Glass Co Ltd and its competitors.

Financials

Balance Sheet Decomposition
Shandong Pharmaceutical Glass Co Ltd

Current Assets 5.4B
Cash & Short-Term Investments 2.4B
Receivables 1.7B
Other Current Assets 1.2B
Non-Current Assets 3.7B
Long-Term Investments 50k
PP&E 2.9B
Intangibles 255.3m
Other Non-Current Assets 511m
Current Liabilities 1.6B
Accounts Payable 650.8m
Accrued Liabilities 18.3m
Short-Term Debt 586.9m
Other Current Liabilities 334m
Non-Current Liabilities 53.8m
Other Non-Current Liabilities 53.8m
Efficiency

Earnings Waterfall
Shandong Pharmaceutical Glass Co Ltd

Revenue
4.9B CNY
Cost of Revenue
-3.6B CNY
Gross Profit
1.3B CNY
Operating Expenses
-451.3m CNY
Operating Income
814.7m CNY
Other Expenses
-76.9m CNY
Net Income
737.7m CNY

Free Cash Flow Analysis
Shandong Pharmaceutical Glass Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

Profitability Score
Profitability Due Diligence

Shandong Pharmaceutical Glass Co Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
Positive Operating Income
55/100
Profitability
Score

Shandong Pharmaceutical Glass Co Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Shandong Pharmaceutical Glass Co Ltd's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Negative Net Debt
Low D/E
85/100
Solvency
Score

Shandong Pharmaceutical Glass Co Ltd's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Shandong Pharmaceutical Glass Co Ltd

Wall Street analysts forecast Shandong Pharmaceutical Glass Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shandong Pharmaceutical Glass Co Ltd is 35.02 CNY with a low forecast of 34.34 CNY and a high forecast of 36.75 CNY.

Lowest
Price Target
34.34 CNY
20% Upside
Average
Price Target
35.02 CNY
22% Upside
Highest
Price Target
36.75 CNY
28% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
Shandong Pharmaceutical Glass Co Ltd

1M 1M
+9%
6M 6M
+1%
1Y 1Y
+7%
3Y 3Y
-29%
5Y 5Y
+64%
10Y 10Y
+484%
Annual Price Range
28.63
52w Low
22.68
52w High
29.82
Price Metrics
Average Annual Return 20.96%
Standard Deviation of Annual Returns 51.36%
Max Drawdown -75%
Shares Statistics
Market Capitalization 19B CNY
Shares Outstanding 663 614 000
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Shandong Pharmaceutical Glass Co Ltd

Country

China

Industry

Health Care

Market Cap

19B CNY

Dividend Yield

0%

Description

Shandong Pharmaceutical Glass Co., Ltd. engages in the research and development, production, and sale of medical glass packaging materials. The company is headquartered in Zibo, Shandong and currently employs 6,171 full-time employees. The company went IPO on 2002-06-03. The firm's products include molded pharmaceutical glass bottles, ampoules, phials, brown bottles, butyl rubber plugs, aluminum tops and others. The firm distributes its products in domestic and overseas markets.

Contact

SHANDONG
Zibo
Yiyuan County
+865333259028
http://www.pharmglass.com/

IPO

2002-06-03

Employees

6 171

Officers

GM & Director
Mr. Jun Zhang
CFO & Director
Mr. Yizhao Song
Deputy GM & Director
Mr. Xingjun Wang
Deputy General Manager
Mr. Bin Du

See Also

Discover More
What is the Intrinsic Value of one Shandong Pharmaceutical Glass Co Ltd stock?

The intrinsic value of one Shandong Pharmaceutical Glass Co Ltd stock under the Base Case scenario is 37.21 CNY.

Is Shandong Pharmaceutical Glass Co Ltd stock undervalued or overvalued?

Compared to the current market price of 28.63 CNY, Shandong Pharmaceutical Glass Co Ltd is Undervalued by 23%.